Number of the records: 1  

Assessing the clinical significance of quality-of-life measures in oncology research: state of the science

  1. SYSc029976
    LBL
      
    ^^^^^nam^^22^^^^^^^^450^
    005
      
    20050120123835.0
    100
      
    $a 20031010d2002 m y0sloc0103 ba
    101
    0-
    $a eng
    102
      
    $a US
    105
      
    $a a oz 100yy
    200
    1-
    $a Assessing the clinical significance of quality-of-life measures in oncology research: state of the science $e Mayo Clinic, Rochester, Minnesota, April 5-6, 2002
    210
      
    $a Hillsborough, N.J. $c Excerpta Medica, a Reed Elsevier Company $d 2002
    215
      
    $a 54 s., il. $c grafy, tab.
    225
    2-
    $a Clinical Therapeutics $e the international peer-reviewed journal of drug therapy $v suppl. B $x 0149-2918
    541
    1-
    $a Stanovenie klinického významu merania kvality života v onkologickom výskume: stav vedy $e Mayo klinika, Rochester, Minnesota, 5.-6.4.2002
    606
    1-
    $a kvalita života $2 mesh $3 sllk_un_auth*d011788 $9 .
    606
    1-
    $a nádory $2 mesh $3 sllk_un_auth*d009369 $9 .
    606
    1-
    $3 sllk_un_auth*d004521 $a hodnotenie vedomostí $9 . $2 mesh
    606
    2-
    $a výskum biomedicínsky $2 mesh $3 sllk_un_auth*d035843 $9 .
    675
      
    $a 616-006 $v 2. $z slo
    712
    12
    $3 sllk_un_auth*k0002062 $a Assessing the Clinical Significance of Quality-of-Life Measures in Oncology Research: State of the Science $b Stretnutie $e Rochester, Minnesota $f 2002 $4 070
    801
    -0
    $a SK $b BA006 $c 20031010 $g AACR2

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.